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2239-Pos Board B225
A Region Involved in Isoform-Specific Regulation of Skeletal Muscle Rya-
nodine Receptor by Calmodulin
Naohiro Yamaguchi, Le Xu, Gerhard Meissner.
Calmodulin (CaM) regulates both skeletal (RyR1) and cardiac (RyR2) muscle
ryanodine receptor calcium channels by binding to a single highly conserved
CaM binding domain (RyR1 amino acid (aa) 3614-3643; RyR2 aa 3581-
3610). CaM inhibits both isoforms at an elevated Ca2þ concentration (micro-
mollar), whereas at cellular resting Ca2þ concentration CaM has opposite
effects on two isoforms (activation of RyR1 and inhibition of RyR2). This im-
plies another region of RyR is involved in isoform-specific CaM regulation at
submicromollar Ca2þ concentration. To identify the regions we constructed
and analyzed a series of RyR1/RyR2 chimera. RyR1/RyR2 chimera carrying
RyR1 aa 1-3725 is inhibited by CaM at 0.4 mMCa2þ (RyR2-type), whereas chi-
mera carrying RyR1 aa 1-4301 is activated (RyR1-type). The results suggest
that RyR1 aa 3726-4301 contains a region that is responsible for CaM activa-
tion. The region overlaps with a domain resembling the sequence of CaM
(CaM-like domain). Replacement of RyR1 3726-4301 with the corresponding
RyR2 sequence confers CaM inhibition at [Ca2þ]<1 mM (RyR2 type). Further-
more, substitution of 5 non-conserved amino acids in RyR1 CaM-like domain
with those of RyR2 (M4122T, I4123L, N4124D, F4125Y, N4130K) is suffi-
cient for RyR2-type CaM inhibition. However, the reverse chimera and mutant
RyR2 were not activated but inhibited by CaM. Taken together, the results sug-
gest that 5 non-conserved amino acids of RyR1 are crucial for RyR1-specific
CaM activation at submicromollar Ca2þ concentration. On the other hand,
CaM inhibition of RyR2 is likely controlled by a different region. Supported
by NIH (AR018687 and HL073051), NSF (EPS-0903795) and AHA
(10SDG3500001).
2240-Pos Board B226
Effect of Human RyR2 CPVT Mutations on Interaction with Calmodulin
Peter Wilson, Michail Nomikos, Matthias Bochtler, F. Anthony Lai.
The ryanodine receptor (RyR) is a member of a family of intracellular calcium
release channels that regulate calcium efflux from intracellular stores. The
RyR2 isoform is most abundant in the heart and plays a key role in cardiac mus-
cle excitation-contraction coupling. Clusters of mutations associated with the
inherited arrhythmogenic disorder, catecholaminergic polymorphic ventricular
tachycardia (CPVT), have been found in specific regions throughout RyR2,
a large protein of ~5000 amino acids. Many of these CPVT mutations (total
>100) are thought to occur in significant functional domains and result in
the dysregulation of RyR channel function.
One such region of RyR2 is believed to comprise a calmodulin (CaM) interac-
tion site and two EF hand motifs. The calcium-sensitive binding of CaM has
been shown to regulate the opening of RyR. Hence, examining the RyR2 inter-
action with CaM and the potential effects of CPVT mutations on this binding
may help reveal mutation-dependent mechanisms of channel dysfunction.
We have prepared bacterial expression plasmid constructs containing the wild-
type human RyR2 CaM-interacting domain and introduced a series of CPVT
mutations that have previously been identified to occur within this region. Ex-
pression and purification of the corresponding recombinant fusion proteins has
enabled calcium-dependent binding of CaM to be determined with all these
constructs. Examining the distinct functional role of calcium concentration
on CaM binding kinetics and further comparative structural analyses of the
wild-type and mutant RyR2 domains may help reveal the specific effect(s)
that CaM-mediated regulation may have in mediating CPVT-linked
arrhythmogenesis.
2241-Pos Board B227
Direct Detection of Domain Peptide Binding to the Cardiac Ryanodine
Receptor (RYR2) using FRET
Florentin R. Nitu, Razvan L. Cornea, David D. Thomas, Bradley R. Fruen.
The RyR2 Ca release channel is activated by the synthetic domain peptide
DPc10, which corresponds to a 36-residue sequence within the channel’s cen-
tral mutation hot-spot region. DPc10 activation is hypothesized to result from
the destabilization of a critical intramolecular interaction between the N-termi-
nal and central hot-spot regions of the full-length RyR2, and to thereby mimic
the effects of arrhythmogenic mutations on this putative intramolecular interac-
tion controlling channel activation. However, the site of DPc10 binding within
the RyR2 3D structure is uncertain, and factors that may modulate binding are
undefined. To directly monitor and map DPc10 binding to the RyR2, we at-
tached a FRET acceptor at DPc10’s N-terminus. A FRET donor was targeted
to the RyR2 cytoplasmic assembly via a fluorescent-labeled FKBP12.6. Addi-
tion of the acceptor-labeled DPc10 (30 mM) resulted in a marked decrease influorescence of the RyR2-bound FKBP12.6. Fluorescence was partially re-
stored upon FKBP12.6 dissociation from the RyR2, indicating that a major
fraction of the total fluorescence decrease was attributable to FRET between
FKBP12.6 and DPc10 when bound to the channel. The DPc10 dependence
of FRET was similar to the DPc10 dependence of RyR2 activation observed
previously in bilayer and ryanodine binding studies (EC50 ~25 mM), consistent
with the likelihood that FRET reflected DPc10 binding at its regulatory site on
the RyR2. FRET decreased as a function of increasing Ca (30 nM to 300 mM),
suggesting that Ca activation of the RyR2 altered either the affinity of DPc10
binding or its proximity to the FKBP12.6 subunit. We conclude that DPc10
binds to a site on the RyR2 within 10 nm of FKBP12.6. Regulatory interactions
and structural changes at this site can be monitored using FRET.
2242-Pos Board B228
b Strand Switching: A Novel Structural Rescue Mechanism in a Dexon3
Cardiac Ryanodine Receptor Mutant
Paolo A. Lobo, Lynn Kimlicka, Ching-Chieh Tung, Filip Van Petegem.
The contraction of cardiac muscle requires release of Ca2þ from the sarcoplas-
mic reticulum through the cardiac ryanodine receptor (RyR2). Several muta-
tions in RyR2 are linked to inherited disorders, including triggered cardiac
arrhythmias such as catecholaminergic polymorphic ventricular tachycardia
(CPVT) that may lead to sudden cardiac death. A severe form of CPVT is
caused by removal of an entire third exon (Dexon3) of RyR2. The 35 deleted
residues form secondary structure elements which are crucial in folding of
the N-terminal domain, raising the question of why the deletion is neither lethal
nor confers a loss-of-function phenotype. A 2.3A˚ crystal structure shows that
the removal results in a structural rescue: an otherwise flexible loop compen-
sates for the loss by inserting itself into the b trefoil domain and increases
the thermal stability. The other b strands in the domain show increased mobility
to accommodate a sequence that bears no similarity to the deleted exon. The
exon3 deletion is not tolerated in the corresponding RyR1 domain. The rescue
shows a novel mechanism by which RyR2 channels can adjust their Ca2þ re-
lease properties through altering the structure of an individual domain.
2243-Pos Board B229
Crystallographic Investigation of Several Malignant Hyperthermia and
CPVT Mutations in Ryanodine Receptors
Lynn Kimlicka, Filip Van Petegem.
Mutations in the Ryanodine Receptor (RYR) are known to underlie many ge-
netic diseases. In particular, the skeletal muscle isoform (RyR1) is involved in
malignant hyperthermia (MH) and central core disease (CCD), whereas muta-
tions in the cardiac isoform (RyR2) are known to cause catecholaminergic
polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventric-
ular dysplasia (ARVD). Despite an extensive analysis of disease mutations on
the functional level, very little is known about the structural changes induced
by the mutations. Here we analyze the structures and stability of over 10 differ-
ent disease mutants. We present crystal structures of mutant versions of the
RyR1 N-terminal disease hot spot, encoding three domains, and of the RyR2
N-terminal domain, all solved between 2.0 and 3.0 Angstrom, and compare
them to the wild type structures. The observed effects on structure and stability
differ substantially among the mutants. Whereas some cause a major destabili-
zation of the overall fold, others mainly cause relative domain-domain move-
ments or confer large conformational changes within individual domains. We
discuss the likely implications of the disease mutations on the overall structure
and gating properties of the intact RyR.
2244-Pos Board B230
AModel-Based Description and Burst Analysis of Purified HumanCardiac
Ryanodine Receptor (hRyR2) Gating Kinetics Under Minimal Conditions
Saptarshi Mukherjee, Nia Lowri Thomas, Chloe E. Maxwell,
Alan J. Williams.
Rhythmic contraction of cardiacmyocytes is maintained by precisely controlled
Ca2þ efflux from intracellular stores mediated by the cardiac ryanodine receptor
(RyR2). Mutations in RyR2 can cause channel instability leading to perturbed
Ca2þ release that can trigger arrhythmias. RyR2-dependent ventricular tachyar-
rhythmia is an important cause of sudden cardiac death, the mechanistic basis of
which remains unclear. Most investigations of RyR2 single channel function
have focussed on the secondary effects ofmutations on channel function through
modulation by regulatory proteins and cellular processes without emphasis on
mutation-dependent effects on the gating behaviour of the channel itself. Here
we describe the gating kinetics of wild-type hRyR2 when activated by its phys-
iological trigger, cytosolic Ca2þ and isolated from the possible modulatory ef-
fects of regulatory factors external to the channel. Single channel experiments
were performed using recombinant, purified hRyR2 under reducing conditions
where the luminal Ca2þ was buffered at 50 nM while the cytosolic Ca2þ was
stringently controlled using EGTA, HEDTA and NTA to achieve an activating
Tuesday, March 8, 2011 415afree Ca2þ range of 0-500mM.The sigmoidal dose-response curve yields an EC50
of 1.4550.44 mM (n=10) and Po saturates at ~10 mM Ca
2þ. The gating model
describes the kinetic behaviour using a minimum of three open and closed states
and incorporates constitutive (unliganded) gatingwhile also revealing very brief
closings suggestive of events similar to C-type inactivation in Kþ channels.
Novel detailed burst analysis of RyR2 elucidates its ligand-bound gating kinet-
ics. The model was further validated by simulation of single channel data. This
model provides a firmplatform for further analysis of the effects of physiological
regulatory factors and dissecting the mechanistic nature of the perturbations in
mutant channels causing cardiovascular pathology. Supported by the British
Heart Foundation.
2245-Pos Board B231
Trans Complementation with the Common G1885E Polymorphism Atten-
uates Mutant RyR2 L433P Channel Dysfunction
Aaron I. Clack, N. Lowri Thomas, Nicole C. Silvester,
Steven R. Barberini-Jammaers, F. Anthony Lai, Christopher H. George.
A channelopathic Leu433Pro (L433P) mutation in the cardiac ryanodine recep-
tor (RyR2) alters intracellular Ca2þ handling and is associated with malignant
arrhythmia. This mutation is reported to exclusively co-inherit with a common
single nucleotide polymorphism (SNP) Gly1885Glu (G1885E) present on the
same allele (i.e. in cis). We investigated the functional impact of the G1885E
SNP on L433P channels. RyR2-null HEK cells were used as the background
for the systematic expression of homo- and heteromeric RyR2 channels com-
posed of recombinant wild-type (WT) subunits, and those containing L433P
and G1885E substitutions. Homomeric G1885E channels were functionally
normal, but Ca2þ handling abnormalities associated with the L433P mutation
were exacerbated by complementation with the G1885E in cis. At the cellular
level, channel dysfunction manifested as reduced caffeine-evoked Ca2þ re-
lease and decreased ER Ca2þ store content. These findings suggest that al-
though L433P is not a typical gain-of-function mutation it augments basal
channel activity. Co-expression of L433P subunits with those containing
G1885E (i.e. in trans complementation) attenuated L433P mutant channel dys-
function. Cells expressing heteromeric assemblies of L433P and G1885E sub-
units exhibited caffeine-activation profiles, homeostatic and post-activation
Ca2þ fluxes and ER Ca2þ loads that were comparable to those typical of
WT channels. Our data show that the genotype, allelic distribution and the re-
sultant mode of L433P and G1885E channel assembly (i.e. cis or trans subunit
complementation) has divergent effects on RyR2 channel (dys)function. The
G1885E SNP may be a complex determinant of channel behaviour in situ
and the potential therapeutic benefits of normalising mutant channel dysfunc-
tion via trans-complementation strategies should be further explored.
2246-Pos Board B232
Differently from S165F, Y141H Mutation of Junctophilin-2 affects
Calcium Signaling in Skeletal Muscle
Jin Seok Woo, Keon Jin Lee, Jianjie Ma, Eun Hui Lee.
Junctophilins (JPs) play an important role in the formation of junctional mem-
brane complexes in muscle cells by physically linking the transverse-tubule and
sarcoplasmic reticulum (SR) membranes. In humans with hypertrophic cardio-
myopathy (HCM), mutations in JP2 are associated to altered Ca2þ signaling in
cardiomyocytes. One of the HCM-related JP2 mutants, S165F also induces
both hypertrophy and altered intracellular Ca2þ signaling in skeletal myotubes.
Here, we tried to identify the dominant negative role of another HCM-related
JP2 mutation, Y141H, in primary mouse skeletal myotubes in order to examine
the effects of Y141H on skeletal muscle function. Consistent with S165F-
expressing skeletal myotubes, over-expression of Y141H led to a significant in-
crease in myotube diameter and resting cytosolic Ca2þ concentration. Immuno-
blot assays suggested that the increased resting cytosolic Ca2þ concentration is
possibly due to the increased expression level of an extracellular Ca2þ-entry
channel, Orai1. Unlike S165F, single myotube Ca2þ imaging experiments
with Y141H-expressing myotubes showed a reduction in the gain of
excitation-contraction coupling without an alteration in both ryanodine
receptor1-mediated Ca2þ release from the SR and the amount of SR Ca2þ.
Therefore, the hypertrophy in the Y141H-expressing skeletal myotubes would
be differently progressed from that in the S165F-expressing skeletal myotubes.
2247-Pos Board B233
Orai1 and STIM1 Expression during Mouse Skeletal Muscle Cell
Differentiation
Keon Jin Lee, Jin Seok Woo, Eun Hui Lee.
In skeletal msucle, stromal interaction molecule 1 (STIM1) is the calcium sen-
sor of sarcoplasmic reticulum and Orai1 is an extracellular Ca2þ-entry channel.
These two proteins are known to be components of store-operated Ca2þ-entry
(SOCE) in skeletal muscle. Here, we examined expression of STIM1 and Orai1during skeletal muscle cell differentiation. During differentiation of primary
mouse skeletal myoblasts to myotubes, Orai1 expression was gradually in-
creased until differentiation day 2 and kept at a certain level on further days
of differentiation. STIM1 expression was increased during differentiation. Im-
munocytochemistry of myoblasts and myotubes with anti-STIM1 and anti-
Orai1 antibodies showed that STIM1 and Orai1 were colocalized all over the
cells except for nucleus parts during differentiation. These results suggest
that SOCE by STIM1 and Orai1 plays a certain role in skeletal muscle
differentiation.
2248-Pos Board B234
Galectin-3 Secreted by Human Umbilical Cord Blood-Derived Mesenchy-
mal Stem Cells Reduces Amyloid-Beta42 Neurotoxicity In Vitro
Ju-Yeon Kim, Dong Hyun Kim, Dal-Soo Kim, Ji Hyun Kim,
Sang Young Jeong, Hong Bae Jeon, Eun Hui Lee, Yoon Sun Yang, Wonil Oh,
Jong Wook Chang.
In this study, we found that expression and secretion of galectin-3 (GAL-3)
were upregulated by amyloid-b42 (Ab42) exposure in human umbilical cord
blood-derived mesenchymal stem cell (hUCB-MSC) without cell death.
Ab42-exposed rat primary cortical neuronal cells co-treated with recombinant
GAL-3 were protected from neuronal death in a dose-dependent manner.
hUCB-MSCs were cocultured with Ab42-exposed rat primary neuronal cells
or the neuroblastoma cell line, SH-SY5Y in a Transwell chamber. Coculture
of hUCB-MSCs reduced cell death of Ab42-exposed neurons and SH-SY5Y
cells. This neuroprotective effect of hUCB-MSCs was reduced significantly
by GAL-3 siRNA. These data suggested that hUCB-MSC-derived GAL-3 is
a survival factor against Ab42 neurotoxicity.
2249-Pos Board B235
Rapamycin is a Deceptive Tool for Probing Functional Interactions
Between FK506-Binding Proteins and Ryanodine Receptors
Elisa Venturi, Samantha J. Pitt, Mano Sitsapesan, Elena Galfre´,
Rebecca Sitsapesan.
Although dissociation of FKBP12/FKBP12.6 from RyR channels is widely ac-
cepted to increase open probability (Po) and induce sub-conductance gating,
these effects are not observed by all investigators. Since rapamycin is fre-
quently used to dissociate FKBP12/FKBP12.6 from RyR channels, we exam-
ined whether rapamycin itself could affect RyR function. When rabbit
skeletal SR vesicles were pre-treated with 20 mM rapamycin, the Po of
RyR1, in the presence of 10 mM cytosolic Ca2þ, was significantly higher
than the Po of channels that had not been exposed to rapamycin
(0.15050.055 vs 0.01650.005; SEM; n=7; p<0.05). Cytosolic addition of
1 mM FKBP12 did not reverse the effects of rapamycin (0.14250.043;
SEM; n=3). Similarly, the Po of RyR2 significantly increased after cytosolic
addition of 20 mM rapamycin in the presence of 10 mM cytosolic Ca2þ, from
0.03950.009 to 0.56450.072 (SEM; n=7; p<0.0001). Again, the effect was
not reversed after perfusing away the rapamycin and after subsequent addition
of 200 nM FKBP12.6. Although FKBP12 and FKBP12.6 were not able to lower
the Po of rapamycin-treated channels, lowering free [Ca2þ] to <1 nM com-
pletely shut all channels demonstrating that sensitivity to Ca2þ was retained.
We observed that rapamycin treatment slightly increased the frequency of re-
solvable sub-conductance gating states (events>3 ms duration) but, for both
RyR1 and RyR2, this appeared to be correlated with elevations in Po. Similarly,
slight changes in sub-conductance state gating after additions of FKBP12/
FKBP12.6 were correlated with Po changes. Our data shows that dissociation
of FKBP12/FKBP12.6 from RyR1/RyR2 does not influence the incidence of
sub-conductance state gating. Moreover, we suggest that the direct actions of
rapamycin on RyR channel gating have led to erroneous conclusions regarding
the effects of FKBP12/FKBP12.6 on RyR channel function.
British Heart Foundation funding
2250-Pos Board B236
Effect of Phosphorylation, Cytoskeleton and FK-506 Binding Protein on
the Gating of Coupled Skeletal Ryanodine Receptors
Jake T. Neumann, Sidney Fleischer, Julio A. Copello.
In skeletal muscle fibers, local Ca2þ sparks and global Ca2þ transients arise
from the synchronous activation of arrays of skeletal ryanodine receptors
(RyR1) in the sarcoplasmic reticulum. Marx et al. (1998) first described that
synchronous Ca2þ signaling in cells could be explained by the coordinated gat-
ing of neighboring RyR1; i.e. coupled gating. We have previously reported that
coupled gating of multiple RyR1 requires luminal Ca2þ as current carrier and
ATP/Mg2þ in the cytosolic solution. As ATP is the most effective nucleotide
for coupled gating in the presence of cytosolic Mg2þ, the role of ATP to mod-
ulate RyR1 as a substrate of protein kinases to phosphorylate the channel or to
stabilize RyR1-RyR1 interactions via the cytoskeleton remains possible.
